Literature DB >> 7773736

Thrombotic thrombocytopenia induced in dogs and pigs. The role of plasma and platelet vWF in animal models of thrombotic thrombocytopenic purpura.

W E Sanders1, R L Reddick, T C Nichols, K M Brinkhous, M S Read.   

Abstract

Thrombotic thrombocytopenia with severe depletion of plasma von Willebrand factor (vWF) was induced in normal large animals (5 dogs and 2 pigs) by botrocetin, a Bothrops factor requiring vWF for platelet agglutination. Botrocetin (90 to 100 U/kg, 2.14 to 2.38 mg/kg, in a single i.v. injection) reduced plasma vWF activity to < 0.1 U/mL for 24 hours. During this period, multimeric analysis of plasma vWF antigen (Ag) revealed the loss of intermediate- and high-molecular-weight forms with a concomitant increase in lower molecular weight forms. A moderate reduction in factor VIII (FVIII) activity was observed. The vWF reduction was accompanied by transient thrombocytopenia and prolonged bleeding times during the deficiency state. Occlusive platelet thrombi were detected by transmission electron microscopy in the microcirculation of lung and spleen but not kidney or brain 30 minutes after the botrocetin injection. Recovery of plasma vWF and platelet count occurred within 48 hours and was associated with the appearance in the plasma of unusually large forms of vWF:Ag multimers. The vWF:Ag multimer distribution was normal at 72 hours. The ultrastructural distribution of vWF in unstimulated normal porcine and canine platelets was examined by using immunogold staining. VWF was detected in the alpha-granules of normal pig platelets but was not observed in platelets from normal dogs. However, both animals developed thrombotic thrombocytopenia when injected with botrocetin. A second group of animals (2 dogs and 3 pigs) with von Willebrand disease (vWD) was given a single botrocetin injection (90 to 100 U/kg). No thrombocytopenia occurred.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7773736     DOI: 10.1161/01.atv.15.6.793

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  12 in total

1.  Force-Regulated Refolding of the Mechanosensory Domain in the Platelet Glycoprotein Ib-IX Complex.

Authors:  X Frank Zhang; Wei Zhang; M Edward Quach; Wei Deng; Renhao Li
Journal:  Biophys J       Date:  2019-04-08       Impact factor: 4.033

2.  Induction of microthrombotic thrombocytopenia in normal mice by transferring a platelet-reactive, monoclonal anti-gp70 autoantibody established from MRL/lpr mice: an autoimmune model of thrombotic thrombocytopenic purpura.

Authors:  K Hashimoto; N Tabata; R Fujisawa; H Matsumura; M Miyazawa
Journal:  Clin Exp Immunol       Date:  2000-01       Impact factor: 4.330

3.  Re-establishment of VWF-dependent Weibel-Palade bodies in VWD endothelial cells.

Authors:  Sandra L Haberichter; Elizabeth P Merricks; Scot A Fahs; Pamela A Christopherson; Timothy C Nichols; Robert R Montgomery
Journal:  Blood       Date:  2004-08-26       Impact factor: 22.113

Review 4.  Glycans and the platelet life cycle.

Authors:  Renhao Li; Karin M Hoffmeister; Hervé Falet
Journal:  Platelets       Date:  2016-05-02       Impact factor: 3.862

5.  Evaluation of von Willebrand factor and von Willebrand factor propeptide in models of vascular endothelial cell activation, perturbation, and/or injury.

Authors:  David A Brott; Anne Katein; Heath Thomas; Michael Lawton; Robert R Montgomery; Rudy J Richardson; Calvert S Louden
Journal:  Toxicol Pathol       Date:  2014-02-04       Impact factor: 1.902

Review 6.  Mechanisms of platelet clearance and translation to improve platelet storage.

Authors:  M Edward Quach; Wenchun Chen; Renhao Li
Journal:  Blood       Date:  2018-02-23       Impact factor: 22.113

7.  Porcine and canine von Willebrand factor and von Willebrand disease: hemostasis, thrombosis, and atherosclerosis studies.

Authors:  Timothy C Nichols; Dwight A Bellinger; Elizabeth P Merricks; Robin A Raymer; Mark T Kloos; Natalie Defriess; Margaret V Ragni; Thomas R Griggs
Journal:  Thrombosis       Date:  2011-02-07

Review 8.  Platelet-Targeted Gene Therapy for Hemophilia.

Authors:  Qizhen Shi
Journal:  Mol Ther Methods Clin Dev       Date:  2018-02-07       Impact factor: 6.698

9.  A rat model of severe VWD by elimination of the VWF gene using CRISPR/Cas9.

Authors:  Jessica Garcia; Veronica H Flood; Sandra L Haberichter; Scot A Fahs; Jeremy G Mattson; Aron M Geurts; Mark Zogg; Hartmut Weiler; Qizhen Shi; Robert R Montgomery
Journal:  Res Pract Thromb Haemost       Date:  2019-12-29

10.  Platelet clearance via shear-induced unfolding of a membrane mechanoreceptor.

Authors:  Wei Deng; Yan Xu; Wenchun Chen; David S Paul; Anum K Syed; Matthew A Dragovich; Xin Liang; Philip Zakas; Michael C Berndt; Jorge Di Paola; Jerry Ware; Francois Lanza; Christopher B Doering; Wolfgang Bergmeier; X Frank Zhang; Renhao Li
Journal:  Nat Commun       Date:  2016-09-27       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.